<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS200106</article-id><article-id pub-id-type="doi">10.1101/2024.11.13.623425</article-id><article-id pub-id-type="archive">PPR939264</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Discovery of lydiamycin A biosynthetic gene cluster in the plant pathogen <italic>Rhodococcus fascians</italic> guides structural revision and identification of molecular target</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ford</surname><given-names>Jonathan J.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Santos-Aberturas</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hems</surname><given-names>Edward S.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sallmen</surname><given-names>Joseph W.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bögeholz</surname><given-names>Lena A. K.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Polturak</surname><given-names>Guy</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="fn" rid="FN1">‡</xref></contrib><contrib contrib-type="author"><name><surname>Osbourn</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Wright</surname><given-names>Joseph A.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Rodnina</surname><given-names>Marina V.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Vereecke</surname><given-names>Danny</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Francis</surname><given-names>Isolde M.</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Truman</surname><given-names>Andrew W.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Molecular Microbiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/055zmrh94</institution-id><institution>John Innes Centre</institution></institution-wrap>, <city>Norwich</city>, <postal-code>NR4 7UH</postal-code>, <country country="GB">United Kingdom</country></aff><aff id="A2"><label>2</label>Department of Physical Biochemistry, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03av75f26</institution-id><institution>Max Planck Institute for Multidisciplinary Sciences</institution></institution-wrap>, <postal-code>37077</postal-code>, <city>Göttingen</city>, <country country="DE">Germany</country></aff><aff id="A3"><label>3</label>Department of Biochemistry and Metabolism, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/055zmrh94</institution-id><institution>John Innes Centre</institution></institution-wrap>, <city>Norwich</city>, <postal-code>NR4 7UH</postal-code>, <country country="GB">United Kingdom</country></aff><aff id="A4"><label>4</label>School of Chemistry, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/026k5mg93</institution-id><institution>University of East Anglia</institution></institution-wrap>, <addr-line>Norwich Research Park</addr-line>, <city>Norwich</city>, <postal-code>NR4 7TJ</postal-code>, <country country="GB">United Kingdom</country></aff><aff id="A5"><label>5</label>Howest University of Applied Sciences, Bruges, Belgium</aff><aff id="A6"><label>6</label>Department of Biology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/019ts0j55</institution-id><institution>California State University</institution></institution-wrap>, <city>Bakersfield</city>, <state>California</state>, <country country="US">USA</country></aff><author-notes><corresp id="CR1"><label>*</label><bold>Corresponding author</bold> <email>andrew.truman@jic.ac.uk</email></corresp><fn fn-type="present-address" id="FN1"><label>‡</label><p id="P1">Current affiliation: Institute of Plant Sciences and Genetics in Agriculture, The Hebrew University of Jerusalem, Rehovot, 7610001, Israel.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>15</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>13</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P2">The natural products actinonin and matlystatin feature an <italic>N</italic>-hydroxy-2-pentyl-succinamyl (HPS) chemophore that facilitates metal chelation and confers their metalloproteinase inhibitory activity. Actinonin is the most potent natural inhibitor of peptide deformylase (PDF) and exerts antimicrobial and herbicidal bioactivity by disrupting protein synthesis. Here, we used a genomics-led approach to identify candidate biosynthetic gene clusters (BGCs) hypothesised to produce novel HPS-containing natural products. We show that one of these BGCs is on the pathogenicity megaplasmid of the plant pathogen <italic>Rhodococcus fascians</italic> and produces lydiamycin A, a macrocyclic pentapeptide. The presence of genes predicted to make a HPS-like chemophore informed the structural recharacterisation of lydiamycin via NMR and crystallography to show it features a rare 2-pentyl-succinyl chemophore. We demonstrate that lydiamycin A inhibits bacterial PDF in vitro and show that a cluster-situated PDF gene confers resistance to lydiamycin A, representing a novel self-immunity mechanism associated with the production of a PDF inhibitor<italic>. In planta</italic> competition assays showed that lydiamycin enhances the fitness of <italic>R. fascians</italic> during plant colonisation. This study highlights how a BGC can inform the structure, biochemical target and ecological function of a natural product.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Natural products (NPs) provide producing organisms with beneficial traits, such as intraspecies communication, nutrient acquisition, or growth inhibition of competing organisms<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. NPs are also critical in medicine and agriculture, where they have diverse uses, including as immunosuppressive, antiparasitic, antifungal and anticancer medicines<sup><xref ref-type="bibr" rid="R2">2</xref></sup>, as well as accounting for the majority of approved antibiotics<sup><xref ref-type="bibr" rid="R3">3</xref></sup>. This success can be attributed to the evolutionarily beneficial selection of potent chemotypes that strongly bind relevant biological targets. Actinonin and matlystatin are structurally related actinobacterial NPs that feature the same <italic>N</italic>-hydroxy-(<italic>R</italic>)-2-pentyl-succinamyl (HPS) chemophore<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref></sup> (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). This chemophore chelates metal ions in the active sites of metalloproteins via a hydroxamate group<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. This activity means that actinonin exhibits nanomolar activity towards multiple targets that have been validated in disease models in mice, including as an anti-tumour candidate<sup><xref ref-type="bibr" rid="R7">7</xref></sup>, acute renal failure<sup><xref ref-type="bibr" rid="R8">8</xref></sup>, anti-malarial<sup><xref ref-type="bibr" rid="R9">9</xref></sup>, anti-obesity<sup><xref ref-type="bibr" rid="R10">10</xref></sup> and anti-bacterial, where the HPS moiety is a structural mimic of <italic>N</italic>-formylmethionine<sup><xref ref-type="bibr" rid="R11">11</xref></sup>, the substrate of the metalloproteinase peptide deformylase (PDF). PDF catalyses the deformylation of the initiator methionine residue on the growing nascent peptide, which is necessary for protein maturation, and is essential for the viability of most bacteria. Synthetic metalloprotease inhibitors inspired by actinonin have also been investigated in clinical trials as antibiotics, including LBM415 and GSK1322322<sup><xref ref-type="bibr" rid="R12">12</xref></sup>.</p><p id="P4">We previously identified BGCs for actinonin and matlystatin<sup><xref ref-type="bibr" rid="R13">13</xref></sup>, which showed that these NPs are biosynthesised by either a non-ribosomal peptide synthetase (NRPS; actinonin<sup><xref ref-type="bibr" rid="R14">14</xref></sup>), or a hybrid NRPS/polyketide synthase (NRPS/PKS; matlystatin), where it was proposed that the HPS moiety was biosynthesised as a coenzyme A (CoA)-bound precursor and condensed at the beginning of the assembly line. A combination of bioinformatic analysis and stable isotope feeding led to a proposal for the biosynthesis of the HPS group (<xref ref-type="fig" rid="F1">Fig. 1A</xref>), although the precise timing of biosynthetic steps remains to be determined. A key step in the proposed pathway is a mutase-catalysed rearrangement to generate the characteristic HPS carbon skeleton. This proposed mutase specificity towards hexylmalonyl-CoA would be specific to HPS biosynthesis, so we hypothesised that it could serve as an effective genetic marker for finding novel HPS-containing NPs.</p><p id="P5"><italic>Rhodococcus fascians</italic> is a plant pathogen that causes leafy gall disease across a broad range of plants and provides a significant economic burden for the ornamental plant industry<sup><xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R17">17</xref></sup>. <italic>R. fascians</italic> is the only plant pathogenic <italic>Rhodococcus</italic> species, where this pathogenicity is determined by the presence of a 199 kb linear virulence plasmid<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup> (pFiD188). Infection symptoms are a result of the production of <italic>Rhodococcus</italic> NPs that interfere with plant growth and development. <italic>R. fascians</italic> therefore represents an agriculturally important model for understanding how small molecules mediate microbial interactions in nature<sup><xref ref-type="bibr" rid="R20">20</xref></sup>. pFiD188 harbours multiple BGCs, including the <italic>fas</italic> BGC responsible for the biosynthesis of cytokinins, which induce the growth of differentiated plant tissue and can lead to gall formation<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. The <italic>att</italic> BGC encodes for production of an autoregulatory compound proposed to be involved in the switch to an endophytic phase<sup><xref ref-type="bibr" rid="R22">22</xref></sup>, while the function of a pFiD188 NRPS BGC was unknown<sup><xref ref-type="bibr" rid="R18">18</xref></sup>.</p><p id="P6">Here, mutase-guided genome mining identified that the NRPS BGC on pFiD188 was predicted to make a putative metalloprotease inhibitor. We show that this BGC (<italic>lyd</italic>) produces the cyclic lipodepsipeptide lydiamycin A, which had been previously isolated from <italic>Streptomyces</italic> spp. as an antimycobacterial antibiotic<sup><xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref></sup>, but was not reported to have an HPS-like moiety. The synteny to the actinonin and matlystatin BGCs prompted a detailed revision of the lydiamycin structure to show that it features a rare HPS-like (<italic>R</italic>)-2-pentyl-succinyl chemophore. We show that lydiamycin is a PDF inhibitor via the identification of a self-immunity gene in the <italic>lyd</italic> BGC and demonstrate that lydiamycin production contributes to microbial competition during leaf colonisation.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Identification of putative metalloprotease inhibitor BGCs</title><p id="P7">To identify BGCs that may produce novel HPS-containing NPs, a phylogenetic analysis of all actinobacterial mutases was performed. A co-association analysis was then performed to determine whether homologues of proposed HPS biosynthesis genes and PKS/NRPS genes were present in the vicinity of mutase genes (<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>), which revealed that a single clade was enriched with potential metalloprotease inhibitor BGCs (<xref ref-type="fig" rid="F1">Fig. 1B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S5</xref>). This clade contained the known BGCs of actinonin (<italic>Streptomyces</italic> sp. ATCC 14903) and matlystatins (<italic>Actinomadura atramentaria</italic> DSM 43919), as well as uncharacterised BGCs from diverse genera, including <italic>Actinoplanes</italic>, <italic>Micromonospora</italic> and <italic>Rhodococcus</italic>.</p><p id="P8"><italic>R. fascians</italic> D188 was further investigated as it is a well-studied plant pathogen<sup><xref ref-type="bibr" rid="R16">16</xref></sup>. The BGC is located on the pFiD188 pathogenicity megaplasmid, which implicated the associated NP as a potential pathogenicity determinant, although the product was unknown<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. This BGC (<xref ref-type="fig" rid="F2">Figs. 2A</xref> and <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S6</xref>), encodes multiple NRPS-associated proteins (LydDHJKL, <xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>), a crotonyl-CoA carboxylase-reductase (CCR, LydM), a hexylmalonyl-CoA epimerase (LydP), α and β subunits of a putative hexylmalonyl-CoA mutase (LydIN) and a MeaB-like protein (LydO), which could aid with mutase function<sup><xref ref-type="bibr" rid="R26">26</xref></sup>. The absence of genes homologous to the asparagine synthetase and <italic>N</italic>-oxygenase genes present in the actinonin and matlystatin BGCs suggested that the <italic>R. fascians</italic> product may instead feature a (<italic>R</italic>)-2-pentyl-succinyl chemophore (<xref ref-type="fig" rid="F1">Fig. 1A</xref>) rather than the full hydroxamic acid moiety. The Stachelhaus specificity code<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup> of a standalone adenylation domain (LydK) is identical to the matlystatin NRPS MatJ (<xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>), which is predicted to activate piperazic acid<sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R29">29</xref></sup>. The predicted incorporation of a piperazic acid residue was supported by the similarity of LydE and LydF to the functionally characterised KtzI/KtzT piperazic acid biosynthetic machinery described in kutzneride biosynthesis<sup><xref ref-type="bibr" rid="R30">30</xref>,<xref ref-type="bibr" rid="R31">31</xref></sup> (47% and 45% identity, respectively). Taken together, these analyses suggested that this BGC makes a non-ribosomal peptide incorporating at least one piperazic acid residue and featuring an intermediate, carboxylated version of the chemophore.</p></sec><sec id="S4"><title>The <italic>R. fascians</italic> D188 pathway makes lydiamycin A</title><p id="P9">To identify the product of the pFiD188 BGC, wild type (WT) <italic>R. fascians</italic> D188 and a mutant featuring a genetically disrupted adenylation domain<sup><xref ref-type="bibr" rid="R18">18</xref></sup> (<italic>R. fascians</italic> D188 Δ<italic>lyd</italic>) were fermented in multiple media and sampled at multiple time points. The metabolomes were then compared using liquid chromatography-mass spectrometry (LC-MS), which provided 20 potential products of the BGC (<xref ref-type="fig" rid="F2">Figs. 2B</xref> and S3-S5). Mass spectral networking analysis indicated that many of these compounds are likely to be structurally related (<xref ref-type="supplementary-material" rid="SD1">Figs. S6-S7</xref>). The mass of the major BGC-associated compound ([M+H]<sup>+</sup> <italic>m/z</italic> 664.3680) (<xref ref-type="supplementary-material" rid="SD1">Fig. S8</xref>) was determined to be identical to lydiamycin A ([M+H]<sup>+</sup> <italic>m/z</italic> 664.3665; 2.3 ppm). Further LC-MS/MS and nuclear magnetic resonance (NMR) spectroscopy analyses of this compound were also fully consistent with previously described lydiamycin A data<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup> (<xref ref-type="supplementary-material" rid="SD1">Fig. S9-S15, Tables S7-S9</xref>). These data indicate that the major product of the <italic>R. fascians</italic> D188 BGC is lydiamycin A and represents the first identification of the lydiamycin A BGC in a non-streptomycete. In parallel to our work, the first lydiamycin BGC was reported<sup><xref ref-type="bibr" rid="R32">32</xref></sup> from a <italic>Streptomyces</italic> species, which is identical to the <italic>Streptomyces aureoverticillatus</italic> BGC in our phylogenetic analysis (<xref ref-type="fig" rid="F2">Fig. 2A</xref>) and is very similar to the <italic>R. fascians</italic> lydiamycin BGC (<xref ref-type="supplementary-material" rid="SD1">Fig. S16</xref>).</p><p id="P10">Lydiamycins are cyclic depsipeptides first identified from <italic>S. lydicus</italic> HKI0343 and have been shown to inhibit mycobacteria, including activity towards a multidrug resistant clinical <italic>M. tuberculosis</italic> strain<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. The published lydiamycin A structure is a macrocyclic pentapeptide with a pentyl-succinic tail<sup><xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref></sup> (<xref ref-type="fig" rid="F2">Fig. 2D</xref>) which partially matched our prediction that the D188 BGC product would feature piperazic acid and a terminal carboxylated moiety. The molecular networking data indicates that <italic>R. fascians</italic> D188 makes lydiamycin congeners that are distinct from the previously described lydiamycins A-H<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R33">33</xref></sup>.</p></sec><sec id="S5"><title>Bioinformatic Analysis Informs a Structure Revision of Lydiamycin A</title><p id="P11">A structural inconsistency of lydiamycin A is apparent when it is compared with actinonin and the matlystatins. Actinonin and matlystatin biosynthesis is proposed to proceed with the condensation of a peptide precursor with the carbonyl of the alpha-proximal thioester of a <italic>N</italic>-hydroxy-2-pentyl-succinamyl-CoA precursor<sup><xref ref-type="bibr" rid="R13">13</xref></sup> (<xref ref-type="fig" rid="F1">Fig.1A</xref>). However, the published lydiamycin A structure (<xref ref-type="fig" rid="F2">Fig. 2D</xref>) necessitates the condensation of a dehydropiperazic acid residue to the carbonyl of the beta-proximal carboxylic acid of a 2-pentyl-succinyl precursor (<xref ref-type="supplementary-material" rid="SD1">Fig. S17</xref>). This disparity is not supported by the presence of any additional genes in the <italic>lyd</italic> BGC that could rationalise this alternative connectivity. Therefore, we hypothesised that lydiamycin A could be biosynthesised via the alpha-proximal condensation and thus instead features a HPS-like carbon skeleton consistent with actinonin and the matlystatins (<xref ref-type="fig" rid="F2">Fig. 2D</xref>).</p><p id="P12">To test this proposal, a greater quantity of lydiamycin A was purified and analysed by NMR. A HMBC cross-peak with H19 allowed the distinction of the piperazic-proximal and piperazic-distal carbonyl carbon atoms as the δ<sub>c</sub> 177.4 ppm and δ<sub>c</sub> 176.0 ppm peaks, respectively (<xref ref-type="fig" rid="F2">Fig. 2C</xref>). Consideration of the relative intensity of HMBC cross-peaks for the 2-pentyl-succinyl carbonyl carbon atoms was more supportive of the revised lydiamycin A structure than the published structure (<xref ref-type="supplementary-material" rid="SD1">Fig. S18</xref>). To further ratify this proposal, 1,1-ADEQUATE NMR (<xref ref-type="fig" rid="F2">Fig. 2C</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S19</xref>) showed that the piperazic-distal carbonyl carbon atom (C31) is adjacent to a carbon with a pair of diastereotopic protons (H30a, H30b; δH 3.33 and 2.63 ppm) and the piperazic-proximal carbonyl carbon atom (C23) is adjacent to a carbon with a single hydrogen (H24; δ<sub>H</sub> 3.05 ppm). The proton multiplicity of these key carbon atoms was also confirmed by HSQC (<xref ref-type="supplementary-material" rid="SD1">Fig. S20</xref>). These observations are consistent only with the proposed revised lydiamycin A structure.</p><p id="P13">To determine the stereochemistry at C24, we reanalysed the phenylglycine methyl ester (PGME) derivatisation experiments published by Hwang and co-workers on lydiamycin from <italic>Streptomyces</italic> sp. GG23<sup><xref ref-type="bibr" rid="R25">25</xref></sup>. We applied the modified Mosher methodology described by Yabuuchi and Kusumi for using PGME derivatives to determine the absolute configuration of β,β-disubstituted propionic acids<sup><xref ref-type="bibr" rid="R34">34</xref></sup>. These data were fully consistent with <italic>R</italic> stereochemistry at C24 of lydiamycin (<xref ref-type="supplementary-material" rid="SD1">Fig. S21</xref>), which is also consistent with the biosynthetic proposal, as the chemophores found in actinonin and matlystatin are stereospecifically biosynthesised as <italic>R</italic> enantiomers<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R35">35</xref></sup>. To further support this structural revision, we acquired X-ray crystallography data from ~30 μm<sup>3</sup> crystals of lydiamycin A, which confirmed the structure at a 0.8 Å resolution (<xref ref-type="fig" rid="F2">Fig. 2D</xref>).</p></sec><sec id="S6"><title>Lydiamycin A inhibits peptide deformylase</title><p id="P14">Actinonin is a potent inhibitor of peptide deformylase (PDF)<sup><xref ref-type="bibr" rid="R6">6</xref></sup>, whereas the mechanism of action of lydiamycin had not been determined and the structural similarity to actinonin had previously not been noted. We therefore hypothesised that a PDF gene at the edge of the <italic>lyd</italic> BGC (<italic>lydA</italic>) could represent a self-immunity mechanism and that PDF is the molecular target of lydiamycin. Lydiamycin lacks the hydroxamate functionality that enables actinonin and matlystatin to tightly bind active site metals, but the carboxylate functionality of the (<italic>R</italic>)-2-pentyl-succinyl moiety could potentially still bind into the PDF active site.</p><p id="P15">Since lydiamycin was previously shown to display anti-mycobacterial activity<sup><xref ref-type="bibr" rid="R23">23</xref></sup>, the non-pathogenic model organism, <italic>Mycobacterium smegmatis</italic> mc2155 was used to assess the role of <italic>lydA in vivo</italic>. Exogenous overexpression of <italic>lydA</italic> rescued <italic>M. smegmatis</italic> to wild-type-like growth when exposed to 50 μM lydiamycin A (<xref ref-type="fig" rid="F4">Fig. 4A</xref>), which was sufficient to prevent growth in the empty vector control or in a strain of <italic>M. smegmatis</italic> overexpressing its native housekeeping PDF gene (<xref ref-type="supplementary-material" rid="SD1">Fig. S22</xref>). This suggests that the <italic>lydA</italic>-mediated resistance is not caused by a titration of lydiamycin A but rather an inherent resistance to the compound. Given that the <italic>lyd</italic> BGC is encoded on plasmid pFiD188, we assessed the lydiamycin sensitivity of wild type <italic>R. fascians</italic> D188 and a pFiD188-free strain (<italic>R. fascians</italic> D188-5). <italic>R. fascians</italic> D188-5 was determined to be at least 60 times more sensitive to lydiamycin A than the <italic>R. fascians</italic> wild type strain (MIC = 10 ug/mL versus &gt;600 μg/mL, respectively; <xref ref-type="supplementary-material" rid="SD1">Fig. S23</xref>). These data indicate that LydA functions as a self-immunity determinant.</p><p id="P16">To understand whether lydiamycin A directly inhibits PDF, <italic>in vitro</italic> assays were conducted with <italic>Escherichia coli</italic> PDF<sup><xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R37">37</xref></sup>, which showed that lydiamycin A exhibits dose-dependent inhibition of this PDF with an IC50 of 6 μM (<xref ref-type="fig" rid="F4">Fig. 4B</xref> and <xref ref-type="supplementary-material" rid="SD1">S24</xref>). There is precedence for an intermediate carboxylated group to confer PDF inhibitory bioactivity, as the same moiety is present in the PDF inhibitor Sch-382583 isolated from a <italic>Streptomyces</italic> species<sup><xref ref-type="bibr" rid="R38">38</xref></sup>, while carboxylated variants of actinonin and matlystatin can inhibit PDF, albeit with significantly reduced potencies<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. These data indicate that lydiamycin is an antimycobacterial agent that functions by peptide deformylase inhibition. There are no PDF genes in the actinonin or matlystatin BGCs, which means that <italic>lydA</italic> represents a novel self-immunity gene associated with the production of a PDF inhibitor. Our genome mining analysis identified multiple BGCs that do encode PDFs (<xref ref-type="fig" rid="F1">Fig. 1B</xref>), indicating that this strategy may exist in currently uncharacterised pathways.</p></sec><sec id="S7"><title>Lydiamycin A is an important ecological agent during niche colonisation</title><p id="P17">As <italic>R. fascians</italic> is the causative agent of leafy gall disease, lydiamycin A was investigated for its involvement in leafy gall disease pathogenesis in <italic>Nicotiana benthamiana</italic> plants<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, especially as actinonin had previously been identified as a chloroplast PDF inhibitor<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. However, there was no significant difference between plant or leafy gall mass for plants infected with either wild type <italic>R. fascians</italic> or <italic>R. fascians</italic> Δ<italic>lyd</italic> and grown for 4 weeks (<xref ref-type="supplementary-material" rid="SD1">Fig. S25</xref>). Equivalent results were obtained for assays for the root length of seedlings and gall development on excised leaves (<xref ref-type="supplementary-material" rid="SD1">Figs. S26-S27</xref>). These data indicate that the production of lydiamycin A is not required for leafy gall disease development and does not have phytotoxic activity. However, LC-MS analysis of <italic>Nicotiana</italic> seedlings and excised leaves infected with either wild type <italic>R. fascians</italic> or <italic>R. fascians</italic> Δ<italic>lyd</italic> (<xref ref-type="fig" rid="F4">Fig. 4C</xref>) indicates that lydiamycin A is reliably produced <italic>in planta</italic> during <italic>R. fascians</italic> infection and suggests that lydiamycin may have an ecologically important role.</p><p id="P18">We hypothesised that the production of lydiamycin during leaf colonisation could instead reflect a role in microbial competition, which was tested by conducting competition assays with plasmid-free <italic>R. fascians</italic> D188-5, which is sensitive to lydiamycin (<xref ref-type="supplementary-material" rid="SD1">Fig. S23</xref>). Here, the impact of lydiamycin production was determined by inoculating sterile <italic>N. benthamiana</italic> seedlings with <italic>R. fascians</italic> D188 WT or Δ<italic>lyd</italic> in a 1:1 mixture with plasmid-free (and lydiamycin sensitive) D188-5. After one week of plant growth, bacterial cells were recovered and the relative amounts of each strain were determined. This experiment indicated that lydiamycin production provides a significant fitness benefit based on the relative fitness ratio of WT/D188-5 compared to <italic>Δlyd</italic>/D188-5 (<xref ref-type="fig" rid="F4">Fig. 4D</xref>), which is consistent with production of an antibiotic inhibiting the growth of a sensitive competitor. More generally, carriage of pFiD188 provides a significant fitness benefit to <italic>R. fascians</italic> during plant colonisation given that D188-5 was outcompeted in both competition assays. A repeat experiment showed a comparable competitive advantage (<xref ref-type="supplementary-material" rid="SD1">Fig. S28</xref>). These data suggest that lydiamycin A production may be important for antagonising rival bacteria that compete for similar resources and therefore enhances the likelihood of <italic>R. fascians</italic> successfully colonising plants.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P19">Metalloproteinase inhibitors are promising lead molecules for a variety of therapeutic targets<sup><xref ref-type="bibr" rid="R41">41</xref></sup>. The HPS moiety in actinonin represents a potent chemophore for the inhibition of multiple therapeutically relevant proteases and hydrolases, including PDF<sup><xref ref-type="bibr" rid="R42">42</xref></sup>. However, currently few NPs have been discovered with a similar chemophore. Here, mutase-guided genome mining enabled us to identify multiple candidate BGCs that we hypothesised produce protease inhibitors. Our discovery that a BGC in <italic>R. fascians</italic> makes lydiamycin was initially unexpected given the dissimilarity between the published lydiamycin structure and actinonin, but extensive NMR analysis, reanalysis of published PGME derivatisation data<sup><xref ref-type="bibr" rid="R25">25</xref></sup> and X-ray crystallography fully supported the structural revision of lydiamycin A (<xref ref-type="fig" rid="F2">Fig. 2D</xref>) to show that it features a (<italic>R</italic>)-2-pentyl-succinyl moiety with the same carbon connectivity and stereochemistry as HPS in actinonin.</p><p id="P20">This discovery highlights how consideration of the biosynthetic pathway can be an important tool to inform structural nuances that could be overlooked by chemical derivatisation or routine NMR analysis<sup><xref ref-type="bibr" rid="R43">43</xref></sup>, which has previously been demonstrated with the biomimetic synthesis and subsequent structural revision of NPs such as hyperelodione D<sup><xref ref-type="bibr" rid="R44">44</xref></sup>. Multiple previous synthetic and analytical studies had been unable to determine the true connectivity of lydiamycin<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R33">33</xref></sup>, where each analysis lacked the critical HMBC correlation between C23 and H19. The connectivity at this part of the molecule was instead originally defined via MS/MS fragmentation<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. A full understanding of the structure and stereochemistry of lydiamycin A now enables accurate structure-activity relationship experiments to be undertaken for both the peptide portion and the (<italic>R</italic>)-2-pentyl-succinyl moiety, especially as its affinity to metalloproteinases is predicted to be modulated by changing the carboxylate to a hydroxamate<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. Metabolomics-based identification of multiple novel lydiamycin congeners from <italic>R. fascians</italic> (<xref ref-type="supplementary-material" rid="SD1">Figs. S3-S7</xref>) provides further natural structural diversity to test for activity, as the masses of these molecules differ to lydiamycin congeners previously identified in other producing organisms<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R33">33</xref></sup>. Notably, the medium had a significant effect on the array of lydiamycin-like molecules produced. These observations highlight the value of investigating related BGCs in different producers, as they may have the potential to make chemodiverse congeners for SAR studies and pharmacological optimisation. For example, novel congeners of the lipodepsipeptide ramoplanin were obtained by the identification of related BGCs<sup><xref ref-type="bibr" rid="R45">45</xref></sup>.</p><p id="P21"><italic>R. fascians</italic> produces the LydA PDF to confer immunity against lydiamycin. There are several reported methods for bacteria gaining resistance against PDF inhibitors, including by PDF mutations<sup><xref ref-type="bibr" rid="R46">46</xref></sup>, maintaining protein synthesis by bypassing formylation<sup><xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup>, efflux of the inhibitor<sup><xref ref-type="bibr" rid="R49">49</xref></sup> or PDF overexpression<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. Overexpression of the housekeeping <italic>M. smegmatis</italic> PDF gene did not confer resistance, which infers that LydA is truly resistant to lydiamycin. Further biochemical work is required to understand the precise structural determinants of this LydA immunity, especially as none of the mutations reported in the literature that confer PDF resistance to inhibitors are present in LydA<sup><xref ref-type="bibr" rid="R46">46</xref>,<xref ref-type="bibr" rid="R51">51</xref></sup>, suggesting that it confers resistance in a novel manner. Our identification of PDF genes in multiple BGCs indicates that this mechanism of immunity may exist for other PDF inhibitors and that PDF genes may represent underexplored markers of antibiotic BGCs, as highlighted by the recent discovery of gammanonin<sup><xref ref-type="bibr" rid="R52">52</xref></sup>. Coassociation of BGCs with copies of antibiotic target genes represents a promising method for antibiotic discovery and an associated understanding of mechanism of action<sup><xref ref-type="bibr" rid="R53">53</xref>–<xref ref-type="bibr" rid="R55">55</xref></sup>, which can be aided by informatic tools such as ARTS<sup><xref ref-type="bibr" rid="R56">56</xref></sup>.</p><p id="P22">PDFs constitute highly promising antimicrobial targets, given the fitness trade-off observed for acquired resistance phenotypes<sup><xref ref-type="bibr" rid="R48">48</xref></sup>. However, hydroxamate-containing PDF inhibitors, such as actinonin, have potentially not succeeded in clinical trials due to their toxicity, which may be associated with the <italic>in vivo</italic> conversion of this chemical moiety into mutagenic isocyanates via Lossen rearrangement<sup><xref ref-type="bibr" rid="R57">57</xref></sup>, which has been implicated in the mutagenicity of hydroxamate-based histone deacetylase inhibitors (HDACIs)<sup><xref ref-type="bibr" rid="R58">58</xref></sup>. Our work highlights how multi-layered genome mining can select for BGCs producing PDF inhibitors carrying the same chemophore backbone but armed with a non-toxic carboxylate as metal chelator. It is possible that natural PDF inhibitors have similar functional logic as synthetic hydroxamate-based HDACIs. These compounds are normally composed of three parts: a cap group that interacts with the surface of the enzymatic target, a linker and a metal chelator moiety<sup><xref ref-type="bibr" rid="R58">58</xref></sup>. Given that matlystatins and actinonin share the same HPS chemophore, it is conceivable that the rest of the molecules acts as the specificity determinant cap. Our definition of the lydiamycin NRPS machinery opens the possibility of creating optimized metalloproteinase inhibitors by combining natural specificity-determinant caps and non-toxic carboxylic acid chelators through combinatorial biosynthesis and NRPS engineering<sup><xref ref-type="bibr" rid="R59">59</xref></sup>.</p><p id="P23"><italic>R. fascians</italic> is an increasingly economically relevant plant pathogen, where it can form long-term biotrophic interactions with the plant host and triggers development of differentiated leafy galls and fasciation<sup><xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref></sup>. The <italic>lyd</italic> BGC is present on the pFiD188 pathogenicity megaplasmid of <italic>R. fascians</italic>, although we found no evidence for lydiamycin involvement in pathogenesis, despite the sensitivity of <italic>Nicotiana</italic> chloroplast PDF to actinonin<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. Instead, leaf-based competition experiments indicate that lydiamycin may play a role in niche colonisation (<xref ref-type="fig" rid="F4">Fig. 4D</xref>). This activity may indirectly impact the establishment of disease and long-term plant colonisation via competition within a complex plant microbiome. Bacterial communities associated with plants are known to be a rich source of antibiotics<sup><xref ref-type="bibr" rid="R60">60</xref>–<xref ref-type="bibr" rid="R62">62</xref></sup>, where they can function to control plant disease<sup><xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R64">64</xref></sup>. The production of antibiotics by pathogens themselves is less well understood or investigated, despite the ability of multiple pathogens to make potent antibiotics<sup><xref ref-type="bibr" rid="R65">65</xref>–<xref ref-type="bibr" rid="R67">67</xref></sup>. An alternative model for lydiamycin production could relate to plasmid fitness, where the capacity to make an antibiotic and confer resistance to the antibiotic could feasibly help counteract the fitness cost of plasmid carriage<sup><xref ref-type="bibr" rid="R68">68</xref></sup>. Production of a diffusible antibiotic could also deter plasmid-free cheater <italic>Rhodococcus</italic> strains in a mixed population, as it is known that plasmid-free <italic>R. fascians</italic> is capable of effectively colonising plants<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R69">69</xref>,<xref ref-type="bibr" rid="R70">70</xref></sup>. These models should be investigated in future experiments with <italic>R. fascians</italic>.</p><p id="P24">In conclusion, our identification of the lydiamycin BGC on the <italic>R. fascians</italic> pFiD188 pathogenicity plasmid has guided the structural recharacterisation of lydiamycin, the identification of its molecular target and prompted an investigation of its role for plant colonisation. Our work should stimulate the rational discovery of further PDF inhibitors, as well as highlighting the potential ecological functions of antibiotic production by microbes.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supporting Information</label><media xlink:href="EMS200106-supplement-Supporting_Information.pdf" mimetype="application" mime-subtype="pdf" id="d62aAcDbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S9"><title>Acknowledgements</title><p>This work was funded by a UK Research and Innovation Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Doctoral Training Partnership grant (BB/M011216/1) for J.J.F. The work was also supported by BBSRC Institute Strategic Programme grants (BBS/E/J/000PR9790 and BB/X01097X/1) for the John Innes Centre (JIC). J.W.S. was funded by BBSRC grant BB/T015349/1. The authors wish to acknowledge the Diamond Light Source for access to beamline i04 under proposal MX32728. This work was supported by the excellent technical assistance at JIC provided by Dr Lionel Hill and Dr Carlo Martins for LC-MS, Dr Martin Rejzek for chemical purification, and Prof. David Lawson and Julia Mundy for crystallography. We are thankful to Dr Catriona Thompson (JIC) for assistance with the statistical analysis of data, and to Prof. Barrie Wilkinson (JIC) for helpful discussions relating to the project.</p></ack><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Bergeijk</surname><given-names>DA</given-names></name><name><surname>Terlouw</surname><given-names>BR</given-names></name><name><surname>Medema</surname><given-names>MH</given-names></name><name><surname>van Wezel</surname><given-names>GP</given-names></name></person-group><article-title>Ecology and genomics of Actinobacteria: new concepts for natural product discovery</article-title><source>Nat Rev Microbiol</source><year>2020</year><volume>18</volume><fpage>546</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">32483324</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group><article-title>Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</article-title><source>J Nat Prod</source><year>2020</year><volume>83</volume><fpage>770</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchings</surname><given-names>MI</given-names></name><name><surname>Truman</surname><given-names>AW</given-names></name><name><surname>Wilkinson</surname><given-names>B</given-names></name></person-group><article-title>Antibiotics: past, present and future</article-title><source>Curr Opin Microbiol</source><year>2019</year><volume>51</volume><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">31733401</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>JJ</given-names></name><name><surname>Kelly</surname><given-names>BK</given-names></name><name><surname>Miller</surname><given-names>GA</given-names></name></person-group><article-title>Actinonin: an antibiotic substance produced by an actinomycete</article-title><source>Nature</source><year>1962</year><volume>195</volume><fpage>701</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">13900478</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haruyama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Matlystatins, new inhibitors of type IV collagenases from Actinomadura atramentaria. III. Structure elucidation of matlystatins A to F</article-title><source>J Antibiot</source><year>1994</year><volume>47</volume><fpage>1473</fpage><lpage>1480</lpage><pub-id pub-id-type="pmid">7844042</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>DZ</given-names></name><etal/></person-group><article-title>Actinonin, a Naturally Occurring Antibacterial Agent, Is a Potent Deformylase Inhibitor</article-title><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>1256</fpage><lpage>1262</lpage><pub-id pub-id-type="pmid">10684604</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>LT</given-names></name><name><surname>Gabrilove</surname><given-names>JL</given-names></name><name><surname>Scheinberg</surname><given-names>DA</given-names></name></person-group><article-title>Antitumor activity of actinonin in vitro and in vivo</article-title><source>Clin Cancer Res</source><year>1998</year><volume>4</volume><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">9516967</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Herzog</surname><given-names>C</given-names></name><name><surname>Kaushal</surname><given-names>GP</given-names></name><name><surname>Gokden</surname><given-names>N</given-names></name><name><surname>Mayeux</surname><given-names>PR</given-names></name></person-group><article-title>Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis</article-title><source>Shock</source><year>2011</year><volume>35</volume><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="pmcid">PMC3265793</pub-id><pub-id pub-id-type="pmid">20577148</pub-id><pub-id pub-id-type="doi">10.1097/SHK.0b013e3181ec39cc</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amberg-Johnson</surname><given-names>K</given-names></name><etal/></person-group><article-title>Small molecule inhibition of apicomplexan FtsH1 disrupts plastid biogenesis in human pathogens</article-title><source>eLife</source><year>2017</year><volume>6</volume><elocation-id>e29865</elocation-id><pub-id pub-id-type="pmcid">PMC5576918</pub-id><pub-id pub-id-type="pmid">28826494</pub-id><pub-id pub-id-type="doi">10.7554/eLife.29865</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Addison</surname><given-names>ML</given-names></name><etal/></person-group><article-title>A Role for Metalloendopeptidases in the Breakdown of the Gut Hormone, PYY3–36</article-title><source>Endocrinology</source><year>2011</year><volume>152</volume><fpage>4630</fpage><lpage>4640</lpage><pub-id pub-id-type="pmid">21952244</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goemaere</surname><given-names>E</given-names></name><etal/></person-group><article-title>New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity</article-title><source>J Antimicrob Chemother</source><year>2012</year><volume>67</volume><fpage>1392</fpage><lpage>1400</lpage><pub-id pub-id-type="pmid">22378679</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corey</surname><given-names>R</given-names></name><etal/></person-group><article-title>Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><fpage>6518</fpage><lpage>6527</lpage><pub-id pub-id-type="pmcid">PMC4249383</pub-id><pub-id pub-id-type="pmid">25136015</pub-id><pub-id pub-id-type="doi">10.1128/AAC.03360-14</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leipoldt</surname><given-names>F</given-names></name><etal/></person-group><article-title>Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><elocation-id>1965</elocation-id><pub-id pub-id-type="pmcid">PMC5719088</pub-id><pub-id pub-id-type="pmid">29213087</pub-id><pub-id pub-id-type="doi">10.1038/s41467-017-01975-6</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>F</given-names></name><etal/></person-group><article-title>Characterization of the Actinonin Biosynthetic Gene Cluster</article-title><source>ChemBioChem</source><year>2018</year><volume>19</volume><fpage>1189</fpage><lpage>1195</lpage><pub-id pub-id-type="pmid">29600569</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stes</surname><given-names>E</given-names></name><name><surname>Vandeputte</surname><given-names>OM</given-names></name><name><surname>Jaziri</surname><given-names>ME</given-names></name><name><surname>Holsters</surname><given-names>M</given-names></name><name><surname>Vereecke</surname><given-names>D</given-names></name></person-group><article-title>A Successful Bacterial Coup d’État: How Rhodococcus fascians Redirects Plant Development</article-title><source>Phytopathology</source><year>2011</year><volume>49</volume><fpage>69</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">21495844</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stes</surname><given-names>E</given-names></name><etal/></person-group><article-title>The leafy gall syndrome induced by Rhodococcus fascians</article-title><source>FEMS Microbiol Lett</source><year>2013</year><volume>342</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">23480693</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putnam</surname><given-names>ML</given-names></name><name><surname>Miller</surname><given-names>ML</given-names></name></person-group><article-title>Rhodococcus fascians in Herbaceous Perennials</article-title><source>Plant Disease</source><year>2007</year><volume>91</volume><fpage>1064</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">30780643</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>I</given-names></name><etal/></person-group><article-title>pFiD188, the linear virulence plasmid of Rhodococcus fascians D188</article-title><source>Mol Plant Microbe Interact</source><year>2012</year><volume>25</volume><fpage>637</fpage><lpage>647</lpage><pub-id pub-id-type="pmid">22482837</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savory</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Phytopathogenic Rhodococcus Have Diverse Plasmids With Few Conserved Virulence Functions</article-title><source>Front Microbiol</source><year>2020</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC7261884</pub-id><pub-id pub-id-type="pmid">32523572</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.01022</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>IM</given-names></name><etal/></person-group><article-title>Mining the genome of Rhodococcus fascians, a plant growth-promoting bacterium gone astray</article-title><source>N Biotechnol</source><year>2016</year><volume>33</volume><fpage>706</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">26877150</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertry</surname><given-names>I</given-names></name><etal/></person-group><article-title>Identification of Rhodococcus fascians cytokinins and their modus operandi to reshape the plant</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>929</fpage><lpage>934</lpage><pub-id pub-id-type="pmcid">PMC2630087</pub-id><pub-id pub-id-type="pmid">19129491</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0811683106</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>T</given-names></name><etal/></person-group><article-title>The att locus of Rhodococcus fascians strain D188 is essential for full virulence on tobacco through the production of an autoregulatory compound</article-title><source>Mol Microbiol</source><year>2001</year><volume>42</volume><fpage>13</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">11679063</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Lydiamycins A-D: cyclodepsipetides with antimycobacterial properties</article-title><source>Angew Chem Int Ed</source><year>2006</year><volume>45</volume><fpage>3067</fpage><lpage>3072</lpage><pub-id pub-id-type="pmid">16619323</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B</given-names></name><etal/></person-group><article-title>Towards the stereochemical assignment of natural lydiamycin A</article-title><source>Chem Commun</source><year>2010</year><volume>46</volume><fpage>574</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">20062866</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Structural Revision of Lydiamycin A by Reinvestigation of the Stereochemistry</article-title><source>Org Lett</source><year>2020</year><volume>22</volume><fpage>3855</fpage><lpage>3859</lpage><pub-id pub-id-type="pmid">32330060</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaccaro</surname><given-names>FA</given-names></name><name><surname>Born</surname><given-names>DA</given-names></name><name><surname>Drennan</surname><given-names>CL</given-names></name></person-group><article-title>Structure of metallochaperone in complex with the cobalamin-binding domain of its target mutase provides insight into cofactor delivery</article-title><source>Proc Natl Acad Sci USA</source><year>2023</year><volume>120</volume><elocation-id>e2214085120</elocation-id><pub-id pub-id-type="pmcid">PMC9974510</pub-id><pub-id pub-id-type="pmid">36787360</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2214085120</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stachelhaus</surname><given-names>T</given-names></name><name><surname>Mootz</surname><given-names>HD</given-names></name><name><surname>Marahiel</surname><given-names>MA</given-names></name></person-group><article-title>The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases</article-title><source>Chem Biol</source><year>1999</year><volume>6</volume><fpage>493</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">10421756</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Röttig</surname><given-names>M</given-names></name><etal/></person-group><article-title>NRPSpredictor2--a web server for predicting NRPS adenylation domain specificity</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>W362</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC3125756</pub-id><pub-id pub-id-type="pmid">21558170</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkr323</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Z-W</given-names></name><etal/></person-group><article-title>Free Piperazic Acid as a Precursor to Nonribosomal Peptides</article-title><source>J Am Chem Soc</source><year>2022</year><volume>144</volume><fpage>13556</fpage><lpage>13564</lpage><pub-id pub-id-type="pmid">35867963</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Biosynthesis of piperazic acid via N5-hydroxy-ornithine in Kutzneria spp. 744</article-title><source>ChemBioChem</source><year>2012</year><volume>13</volume><fpage>972</fpage><lpage>976</lpage><pub-id pub-id-type="pmcid">PMC3463134</pub-id><pub-id pub-id-type="pmid">22522643</pub-id><pub-id pub-id-type="doi">10.1002/cbic.201200054</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>D</given-names></name><etal/></person-group><article-title>Targeted and Logical Discovery of Piperazic Acid-Bearing Natural Products Based on Genomic and Spectroscopic Signatures</article-title><source>J Am Chem Soc</source><year>2023</year><volume>145</volume><fpage>19676</fpage><lpage>19690</lpage><pub-id pub-id-type="pmid">37642383</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libis</surname><given-names>V</given-names></name><etal/></person-group><article-title>Multiplexed mobilization and expression of biosynthetic gene clusters</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>5256</elocation-id><pub-id pub-id-type="pmcid">PMC9448795</pub-id><pub-id pub-id-type="pmid">36068239</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-32858-0</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Bioactive Piperazic Acid-Bearing Cyclodepsipeptides, Lydiamycins E-H, from an Endophytic Streptomyces sp. Associated with Cinnamomum cassia</article-title><source>J Nat Prod</source><year>2023</year><volume>86</volume><fpage>751</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">36812487</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yabuuchi</surname><given-names>T</given-names></name><name><surname>Kusumi</surname><given-names>T</given-names></name></person-group><article-title>Phenylglycine Methyl Ester, a Useful Tool for Absolute Configuration Determination of Various Chiral Carboxylic Acids</article-title><source>J Org Chem</source><year>2000</year><volume>65</volume><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">10813947</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>NH</given-names></name><name><surname>Ollis</surname><given-names>WD</given-names></name><name><surname>Thorpe</surname><given-names>JE</given-names></name><name><surname>Ward</surname><given-names>AD</given-names></name></person-group><article-title>Studies concerning the antibiotic actinonin. Part II. Total synthesis of actinonin and some structural analogues by the isomaleimide method</article-title><source>J Chem Soc, Perkin Trans</source><year>1975</year><volume>1</volume><fpage>825</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">1170209</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>KT</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name></person-group><article-title>High-Throughput Screening of Peptide Deformylase Inhibitors</article-title><source>Methods Mol Med</source><year>2008</year><volume>142</volume><fpage>117</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">18437310</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bögeholz</surname><given-names>LAK</given-names></name><name><surname>Mercier</surname><given-names>E</given-names></name><name><surname>Wintermeyer</surname><given-names>W</given-names></name><name><surname>Rodnina</surname><given-names>MV</given-names></name></person-group><article-title>Kinetic control of nascent protein biogenesis by peptide deformylase</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><elocation-id>24457</elocation-id><pub-id pub-id-type="pmcid">PMC8712518</pub-id><pub-id pub-id-type="pmid">34961771</pub-id><pub-id pub-id-type="doi">10.1038/s41598-021-03969-3</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Isolation and structure elucidation of two novel deformylase inhibitors produced by Streptomyces sp</article-title><source>Tetrahedron Lett</source><year>2001</year><volume>42</volume><fpage>3549</fpage><lpage>3551</lpage></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madison</surname><given-names>V</given-names></name><etal/></person-group><article-title>Binding affinities and geometries of various metal ligands in peptide deformylase inhibitors</article-title><source>Biophys Chem</source><year>2002</year><volume>101</volume><fpage>239</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">12488004</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>CX</given-names></name><etal/></person-group><article-title>Plant peptide deformylase: a novel selectable marker and herbicide target based on essential cotranslational chloroplast protein processing</article-title><source>Plant Biotechnol J</source><year>2007</year><volume>5</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">17309682</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaysser</surname><given-names>L</given-names></name></person-group><article-title>Built to bind: biosynthetic strategies for the formation of small-molecule protease inhibitors</article-title><source>Nat Prod Rep</source><year>2019</year><volume>36</volume><fpage>1654</fpage><lpage>1686</lpage><pub-id pub-id-type="pmid">30976762</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilloteau</surname><given-names>J-P</given-names></name><etal/></person-group><article-title>The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents</article-title><source>J Mol Biol</source><year>2002</year><volume>320</volume><fpage>951</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">12126617</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>PD</given-names></name><name><surname>Lawrence</surname><given-names>AL</given-names></name></person-group><article-title>The importance of asking “how and why?” in natural product structure elucidation</article-title><source>Nat Prod Rep</source><year>2017</year><volume>34</volume><fpage>1193</fpage><lpage>1202</lpage><pub-id pub-id-type="pmid">28850146</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franov</surname><given-names>LJ</given-names></name><name><surname>Hart</surname><given-names>JD</given-names></name><name><surname>Pullella</surname><given-names>GA</given-names></name><name><surname>Sumby</surname><given-names>CJ</given-names></name><name><surname>George</surname><given-names>JH</given-names></name></person-group><article-title>Bioinspired Total Synthesis of Erectones A and B, and the Revised Structure of Hyperelodione D</article-title><source>Angew Chem Int Ed</source><year>2022</year><volume>61</volume><elocation-id>e202200420</elocation-id><pub-id pub-id-type="pmcid">PMC9314102</pub-id><pub-id pub-id-type="pmid">35225410</pub-id><pub-id pub-id-type="doi">10.1002/anie.202200420</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>KT</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>McCafferty</surname><given-names>DG</given-names></name></person-group><article-title>Discovery of Six Ramoplanin Family Gene Clusters and the Lipoglycodepsipeptide Chersinamycin</article-title><source>ChemBioChem</source><year>2021</year><volume>22</volume><fpage>176</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">32805078</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosowska-Shick</surname><given-names>K</given-names></name><etal/></person-group><article-title>Multistep Resistance Selection and Postantibiotic-Effect Studies of the Antipneumococcal Activity of LBM415 Compared to Other Agents</article-title><source>Antimicrob Agents Chemother</source><year>2006</year><volume>51</volume><fpage>770</fpage><lpage>773</lpage><pub-id pub-id-type="pmcid">PMC1797776</pub-id><pub-id pub-id-type="pmid">17116666</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01150-06</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name></person-group><article-title>The Inhibition and Resistance Mechanisms of Actinonin, Isolated from Marine Streptomyces sp. NHF165, against Vibrio anguillarum</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><elocation-id>1467</elocation-id><pub-id pub-id-type="pmcid">PMC5020083</pub-id><pub-id pub-id-type="pmid">27679625</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.01467</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolis</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Peptide Deformylase in Staphylococcus aureus: Resistance to Inhibition Is Mediated by Mutations in the Formyltransferase Gene</article-title><source>Antimicrob Agents Chemother</source><year>2000</year><volume>44</volume><fpage>1825</fpage><lpage>1831</lpage><pub-id pub-id-type="pmcid">PMC89968</pub-id><pub-id pub-id-type="pmid">10858337</pub-id><pub-id pub-id-type="doi">10.1128/aac.44.7.1825-1831.2000</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Role of the AcrAB-TolC Efflux Pump in Determining Susceptibility of Haemophilus influenzae to the Novel Peptide Deformylase Inhibitor LBM415</article-title><source>Antimicrob Agents Chemother</source><year>2005</year><volume>49</volume><fpage>3129</fpage><lpage>3135</lpage><pub-id pub-id-type="pmcid">PMC1196275</pub-id><pub-id pub-id-type="pmid">16048914</pub-id><pub-id pub-id-type="doi">10.1128/AAC.49.8.3129-3135.2005</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Reduced Susceptibility of Haemophilus influenzae to the Peptide Deformylase Inhibitor LBM415 Can Result from Target Protein Overexpression Due to Amplified Chromosomal def Gene Copy Number</article-title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><fpage>1004</fpage><lpage>1010</lpage><pub-id pub-id-type="pmcid">PMC1803149</pub-id><pub-id pub-id-type="pmid">17220413</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01103-06</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolis</surname><given-names>P</given-names></name><etal/></person-group><article-title>Resistance of Streptococcus pneumoniae to Deformylase Inhibitors Is Due to Mutations in defB</article-title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><fpage>2432</fpage><lpage>2435</lpage><pub-id pub-id-type="pmcid">PMC90673</pub-id><pub-id pub-id-type="pmid">11502510</pub-id><pub-id pub-id-type="doi">10.1128/AAC.45.9.2432-2435.2001</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>JH</given-names></name><name><surname>Adams</surname><given-names>EE</given-names></name><name><surname>Johnston</surname><given-names>CW</given-names></name></person-group><article-title>Discovery and description of gammanonin: a widely distributed natural product from Gammaproteobacteria</article-title><source>bioRxiv</source><year>2024</year><elocation-id>2024.08.13.607837</elocation-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almabruk</surname><given-names>KH</given-names></name><name><surname>Dinh</surname><given-names>LK</given-names></name><name><surname>Philmus</surname><given-names>B</given-names></name></person-group><article-title>Self-Resistance of Natural Product Producers: Past, Present, and Future Focusing on Self-Resistant Protein Variants</article-title><source>ACS Chem Biol</source><year>2018</year><volume>13</volume><fpage>1426</fpage><lpage>1437</lpage><pub-id pub-id-type="pmid">29763292</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Recent developments in self-resistance gene directed natural product discovery</article-title><source>Nat Prod Rep</source><year>2020</year><volume>37</volume><fpage>879</fpage><lpage>892</lpage><pub-id pub-id-type="pmcid">PMC7340575</pub-id><pub-id pub-id-type="pmid">31912842</pub-id><pub-id pub-id-type="doi">10.1039/c9np00050j</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>NP</given-names></name><name><surname>Wahl</surname><given-names>KL</given-names></name><name><surname>Steenwyk</surname><given-names>JL</given-names></name><name><surname>Rokas</surname><given-names>A</given-names></name><name><surname>Eichman</surname><given-names>BF</given-names></name></person-group><article-title>Resistance-Guided Mining of Bacterial Genotoxins Defines a Family of DNA Glycosylases</article-title><source>mBio</source><year>2022</year><volume>13</volume><elocation-id>e0329721</elocation-id><pub-id pub-id-type="pmcid">PMC9040887</pub-id><pub-id pub-id-type="pmid">35311535</pub-id><pub-id pub-id-type="doi">10.1128/mbio.03297-21</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mungan</surname><given-names>MD</given-names></name><etal/></person-group><article-title>ARTS 2.0: feature updates and expansion of the Antibiotic Resistant Target Seeker for comparative genome mining</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>W546</fpage><lpage>W552</lpage><pub-id pub-id-type="pmcid">PMC7319560</pub-id><pub-id pub-id-type="pmid">32427317</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkaa374</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>M</given-names></name><etal/></person-group><article-title>The Lossen rearrangement from free hydroxamic acids</article-title><source>Org Biomol Chem</source><year>2019</year><volume>17</volume><fpage>5420</fpage><lpage>5427</lpage><pub-id pub-id-type="pmid">31090777</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Kozikowski</surname><given-names>AP</given-names></name></person-group><article-title>Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors—What Some May Have Forgotten or Would Rather Forget?</article-title><source>ChemMedChem</source><year>2016</year><volume>11</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC4765907</pub-id><pub-id pub-id-type="pmid">26603496</pub-id><pub-id pub-id-type="doi">10.1002/cmdc.201500486</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozhüyük</surname><given-names>KA</given-names></name><name><surname>Micklefield</surname><given-names>J</given-names></name><name><surname>Wilkinson</surname><given-names>B</given-names></name></person-group><article-title>Engineering enzymatic assembly lines to produce new antibiotics</article-title><source>Curr Opin Microbiol</source><year>2019</year><volume>51</volume><fpage>88</fpage><lpage>96</lpage><pub-id pub-id-type="pmcid">PMC6908967</pub-id><pub-id pub-id-type="pmid">31743841</pub-id><pub-id pub-id-type="doi">10.1016/j.mib.2019.10.007</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfrich</surname><given-names>EJN</given-names></name><etal/></person-group><article-title>Bipartite interactions, antibiotic production and biosynthetic potential of the Arabidopsis leaf microbiome</article-title><source>Nat Microbiol</source><year>2018</year><volume>3</volume><fpage>909</fpage><lpage>919</lpage><pub-id pub-id-type="pmcid">PMC7115891</pub-id><pub-id pub-id-type="pmid">30038309</pub-id><pub-id pub-id-type="doi">10.1038/s41564-018-0200-0</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meij</surname><given-names>A</given-names></name><name><surname>Worsley</surname><given-names>SF</given-names></name><name><surname>Hutchings</surname><given-names>MI</given-names></name><name><surname>xsvan Wezel</surname><given-names>GP</given-names></name></person-group><article-title>Chemical ecology of antibiotic production by actinomycetes</article-title><source>FEMS Microbiol Rev</source><year>2017</year><volume>41</volume><fpage>392</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">28521336</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Induction of antibiotic specialized metabolism by co-culturing in a collection of phyllosphere bacteria</article-title><source>Environ Microbiol</source><year>2021</year><volume>23</volume><fpage>2132</fpage><lpage>2151</lpage><pub-id pub-id-type="pmid">33393154</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco-Moreno</surname><given-names>A</given-names></name><etal/></person-group><article-title>Pan-genome analysis identifies intersecting roles for Pseudomonas specialized metabolites in potato pathogen inhibition</article-title><source>eLife</source><year>2021</year><volume>10</volume><elocation-id>e71900</elocation-id><pub-id pub-id-type="pmcid">PMC8719888</pub-id><pub-id pub-id-type="pmid">34792466</pub-id><pub-id pub-id-type="doi">10.7554/eLife.71900</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrión</surname><given-names>VJ</given-names></name><etal/></person-group><article-title>Pathogen-induced activation of disease-suppressive functions in the endophytic root microbiome</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">31672892</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crone</surname><given-names>W</given-names></name><name><surname>Leeper</surname><given-names>FJ</given-names></name><name><surname>Truman</surname><given-names>AW</given-names></name></person-group><article-title>Identification and characterisation of the gene cluster for the anti-MRSA antibiotic bottromycin: expanding the biosynthetic diversity of ribosomal peptides</article-title><source>Chem Sci</source><year>2012</year><volume>3</volume><fpage>3516</fpage><lpage>3521</lpage></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>KM</given-names></name><name><surname>Reck</surname><given-names>M</given-names></name><name><surname>Bowman</surname><given-names>GR</given-names></name><name><surname>Wencewicz</surname><given-names>TA</given-names></name></person-group><article-title>Tabtoxinine-β-lactam is a “stealth” β-lactam antibiotic that evades β-lactamase-mediated antibiotic resistance</article-title><source>MedChemComm</source><year>2015</year><volume>7</volume><fpage>118</fpage><lpage>127</lpage></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meza-Torres</surname><given-names>J</given-names></name><etal/></person-group><article-title>Listeriolysin S: A bacteriocin from Listeria monocytogenes that induces membrane permeabilization in a contact-dependent manner</article-title><source>Proc Nat Acad Sci USA</source><year>2021</year><volume>118</volume><elocation-id>e2108155118</elocation-id><pub-id pub-id-type="pmcid">PMC8501752</pub-id><pub-id pub-id-type="pmid">34599102</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2108155118</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockhurst</surname><given-names>MA</given-names></name><name><surname>Harrison</surname><given-names>E</given-names></name></person-group><article-title>Ecological and evolutionary solutions to the plasmid paradox</article-title><source>Trends Microbiol</source><year>2022</year><volume>30</volume><fpage>534</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">34848115</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savory</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Evolutionary transitions between beneficial and phytopathogenic Rhodococcus challenge disease management</article-title><source>eLife</source><year>2017</year><volume>6</volume><elocation-id>e30925</elocation-id><pub-id pub-id-type="pmcid">PMC5726852</pub-id><pub-id pub-id-type="pmid">29231813</pub-id><pub-id pub-id-type="doi">10.7554/eLife.30925</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelis</surname><given-names>K</given-names></name><etal/></person-group><article-title>The Plant Pathogen Rhodococcus fascians Colonizes the Exterior and Interior of the Aerial Parts of Plants</article-title><source>Mol Plant-Microbe Interact</source><year>2001</year><volume>14</volume><fpage>599</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">11332724</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Mutase-guided BGC discovery.</title><p>A. Proposed HPS biosynthesis for actinonin and matlystatin. B. Clade of actinobacterial mutases that are highly co-associated with the proposed HPS biosynthesis genes (colour-coded as in panel A), NRPS/PKS genes (red) and peptide deformylase gene (green). A filled circle indicates the presence of a homologous gene in proximity to the mutase gene. The actinonin and matlystatin producers are indicated in red. Asterisks indicate where BGCs are at the end of a contig and may therefore be incomplete. Abbreviations: CCR = crotonyl-CoA carboxylase-reductase, asparagine synthetase, <italic>N</italic>-oxygenase, NRPS(A) = NRPS adenylation domain, NRPS(C) = NRPS condensation domain, PKS(KS) = PKS ketosynthase domain, CP = acyl or peptidyl carrier protein, TE = thioesterase.</p></caption><graphic xlink:href="EMS200106-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Characterisation of lydiamycin from <italic>R. fascians.</italic></title><p>A. Similarity comparison of the actinonin, matlystatin and lydiamycin BGCs. Gene identity percentage is represented by the grayscale links between genes. Pip = piperazic acid. B. Comparison of LC-MS chromatograms of WT R. fascians D188 and a strain with a deletion in the lydiamycin BGC (Δ<italic>lyd</italic>). C. Representative regions of 2D HMBC and 1,1-ADEQUATE NMR spectra with key correlations highlighted for the 2-pentyl-succinyl portion of the molecule. D. Comparison of the previously proposed lydiamycin A structure alongside the revised structure and the associated crystal structure.</p></caption><graphic xlink:href="EMS200106-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Proposed biosynthesis of lydiamycin A.</title><p>A. <italic>lyd</italic> BGC is colour-coded as in <xref ref-type="fig" rid="F2">Fig. 2A</xref> as well as genes encoding a PDF (LydA) in blue, a LuxR-type regulator in teal, a prenyltransferase in grey, a flavin-dependent oxidoreductase in black. See <xref ref-type="supplementary-material" rid="SD1">Table S6</xref> for further BGC details. B. Biosynthetic proposal for lydiamycin. The timing of piperazic acid dehydrogenation is not known and may occur post-assembly line, given that LydK has an identical recognition sequence to Pip-selective MatJ in matlystatin biosynthesis (<xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>).</p></caption><graphic xlink:href="EMS200106-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Biological activity of lydiamycin A.</title><p>A. Growth curves of <italic>M. smegmatis</italic> expressing either empty vector or the PDF gene encoded in the lydiamycin BGC (LydA), in the absence or presence of 50 μM lydiamycin A. The standard error of the mean is illustrated by the shaded envelope (n=3 for controls, n=6 for experiments with lydiamycin). B. <italic>In vitro</italic> inhibition of <italic>E. coli</italic> PDF by lydiamycin A. Initial velocities V<sub>0</sub> of PDF activity with a model peptide (formyl-methionyl-leucyl-p-nitroaniline, <xref ref-type="supplementary-material" rid="SD1">Fig. S24</xref>) were fitted to a sigmoidal function. Error bars represent the standard deviation of three independent experiments, n=3. C. Production of lydiamycin A by <italic>R. fascians</italic> during colonisation of <italic>N. benthamiana</italic> seedlings. Extracted ion chromatograms (EICs) are shown for <italic>m/z</italic> 664.3665 (+/- 5 ppm) from LC-MS experiments. D. Competition assay of plasmid-free <italic>R. fascians</italic> (D188-5) against WT and Δ<italic>lyd</italic> strains. The relative fitness of each test strain was calculated as compared to the plasmid-free strain. Individual replicates are indicated as dots. The mean of these replicates is shown as a black cross-bar and error bars indicate the standard error of the mean. A two-tailed t-test showed a significant different between WT and Δ<italic>lyd</italic> relative fitness values (<italic>p</italic> = 0.0068).</p></caption><graphic xlink:href="EMS200106-f004"/></fig></floats-group></article>